ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Athersys, Inc. (ATHX) stock declined over -33.50%, trading at $0.01 on NASDAQ, down from the previous close of $0.02. The stock opened at $0.02, fluctuating between $0.01 and $0.02 in the recent session.
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.
Employees | 24 |
Beta | -0.9 |
Sales or Revenue | $5.33M |
5Y Sales Change% | 17% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Athersys, Inc. (NASDAQ: ATHX) stock price is $0.01 in the last trading session. During the trading session, ATHX stock reached the peak price of $0.02 while $0.01 was the lowest point it dropped to. The percentage change in ATHX stock occurred in the recent session was -33.5% while the dollar amount for the price change in ATHX stock was -$0.01.
The NASDAQ listed ATHX is part of Biotechnology industry that operates in the broader Healthcare sector. Athersys, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Alison O'Sullivan M.B.A.
Vice President of HR
Mr. David Russ M.B.A.
Vice President of Supply Chain, Fin. & Admin.
Dr. Sarah Busch Ph.D.
Vice President of Regenerative Medicine & Head of Bus. Devel.
Ms. Maia A. Hansen M.B.A., M.S.
Chief Operating Officer
Ms. Z. Kasey Rosado
Interim Chief Financial Officer
Dr. Manal Morsy M.B.A., M.D., PH.D.
Executive Vice President & Head of Global Regulatory Affairs
Ms. Ellen Gurley
Mang. of Corporation Communications and Investor Relations
Mr. Rakesh Ramachandran MS
Head of Information Technology & Communications and Vice President
Dr. Robert Mays Ph.D.
Executive Vice President, Head of Regenerative Medicine & Neuroscience Programs
Mr. James Glover B.S., P.M.P.
Executive Vice President & Head of Manufacturing
Mr. Daniel A. Camardo M.B.A.
Chief Executive Officer, Sec., Principal Accounting Officer & Director
Senthil Ranganathan Ph.D.
Vice President of Technical Operations
ATHX's closing price is 200% higher than its 52-week low of $0.00 where as its distance from 52-week high of $1.99 is -99.32%.
Number of ATHX employees currently stands at 24.
Official Website of ATHX is: https://www.athersys.com
ATHX could be contacted at phone 216 431 9900 and can also be accessed through its website. ATHX operates from 3201 Carnegie Avenue, Cleveland, OH 44115-2634, United States.
ATHX stock volume for the day was 6.46M shares. The average number of ATHX shares traded daily for last 3 months was 1.77M.
The market value of ATHX currently stands at $0.00 with its latest stock price at $0.01 and 0 of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com